Pharming Group N.V. Files 6-K with Press Release

TL;DR

Pharming Group N.V. dropped a 6-K filing with a press release on April 30, 2025.

AI Summary

Pharming Group N.V. filed a Form 6-K on April 30, 2025, to furnish a press release dated April 30, 2025. The press release, filed as Exhibit 99.1, is the primary content of this filing. No specific financial figures or operational details were provided in the header information.

Why It Matters

This filing indicates that Pharming Group N.V. is providing updated information to the SEC, likely related to recent business developments or announcements that are material to investors.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of a press release and does not contain new financial data or significant operational changes that would inherently increase risk.

Key Players & Entities

• Pharming Group N.V. (company) — Registrant
• 001-39822 (dollar_amount) — SEC File Number
• April 30, 2025 (date) — Filing Date

FAQ

From the Filing

0001828316-25-000025.txt : 20250430 0001828316-25-000025.hdr.sgml : 20250430 20250430115045 ACCESSION NUMBER: 0001828316-25-000025 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250430 FILED AS OF DATE: 20250430 DATE AS OF CHANGE: 20250430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharming Group N.V. CENTRAL INDEX KEY: 0001828316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39822 FILM NUMBER: 25892620 BUSINESS ADDRESS: STREET 1: DARWINWEG 24 CITY: LEIDEN STATE: P7 ZIP: 2333 CR BUSINESS PHONE: 31 (0)71 5247 400 MAIL ADDRESS: STREET 1: DARWINWEG 24 CITY: LEIDEN STATE: P7 ZIP: 2333 CR FORMER COMPANY: FORMER CONFORMED NAME: Pharming Group Group N.V. DATE OF NAME CHANGE: 20201014 6-K 1 pharminggroupannouncesthe2.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2025 Commission File Number: 001-39822 Pharming Group N.V. (Exact Name of Registrant as Specified in Its Charter) Darwinweg 24 2333 CR Leiden The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐ Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of Pharming Group N.V., or the Company, dated April 30, 2025. EXHIBIT INDEX Exhibit No. Description 99.1 Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Pharming Group N.V. By: /s/ Fabrice Chouraqui Name: Fabrice Chouraqui Title: CEO Date: April 30, 2025 Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”) will be held on Wednesday June 11, 2025, at 14:00 CEST. The Notice to Convene, Explanatory Notes, Proxy and other meeting documents for the AGM can be found on the Company’s website under Investors/Shareholder Meetings. The Board of Directors has decided to nominate Dr. Elaine Sullivan at the AGM for the appointment as a new Non-Executive Director for a term of four years. The terms of Mrs. Deborah Jorn and Mr. Steven Baert are scheduled to expire at the AGM and they are not available for reappointment. The agenda of the AGM also includes the reappointments of Mrs. Jabine van der Meijs and Mr. Leonard Kruimer as Non-Executive Directors, the proposal to reappoint Deloitte Accountants B.V. as the external auditor of the Company for the financial year 2025, and the renewal of the authorizations for the Board of Directors to issue shares (including rights to acquire shares), and to repurchase shares. The AGM will be held at the Corpus Congress Centre, Willem Einthovenstraat 1, 2342 BH in Oegstgeest, the Netherlands, and will be webcast live. Profile Dr. Elaine Sullivan (date of birth: February 6, 1961, British and Irish citizen) i